Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions

Nicole Paland, Haya Hamza, Antonina Pechkovsky, Miran Aswad, Dayana Shagidov, Igal Louria-Hayon

Research output: Contribution to journalReview articlepeer-review

Abstract

Rheumatoid diseases, including rheumatoid arthritis, osteoarthritis, and fibromyalgia, are characterized by progressive inflammation in the musculoskeletal system, predominantly affecting the joints and leading to cartilage and bone damage. The resulting pain and ongoing degradation of the musculoskeletal system contribute to reduced physical activity, ultimately impacting quality of life and imposing a substantial socioeconomic burden. Unfortunately, current therapeutics have limited efficacy in slowing disease progression and managing pain. Thus, the development of novel and alternative therapies is imperative.

Original languageEnglish
Article numbere0022
JournalRambam Maimonides Medical Journal
Volume14
Issue number4
DOIs
StatePublished - 29 Oct 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 Paland et al.

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions'. Together they form a unique fingerprint.

Cite this